PPH vs IVV

APPH

BIVV

Measures won1–5IVV wins · of 6 · 5Y

$10,000 · 5Y$17,530IVV · PPH $17,454

Lowest cost0.03%IVV · $3 on $10k

Most income1.76%PPH · $176 on $10k

Smallest drop−8.9%IVV · worst fall in 1Y

Held in common5.0%PPH and IVV

VanEck Pharmaceutical ETF · $1.1BiShares Core S&P 500 ETF · $883B

+18.8%3 years · per year$16,767 · $18,122+21.9%

+11.8%5 years · per year$17,454 · $17,530+11.9%

0.36%Expense ratio$36 · $3 on $10k · lower wins0.03%

1.76%12-mo yield$176 · $110 on $10k1.10%

End-of-day Nov 11, 2026 · $10,000 5 years ago, dividends reinvested · ● winner of the row · each row scaled to the bigger of the two

5Y2 funds

#			Trend
1	BIVV	iShares Core S&P 500 ETFRead Desk		0.03%	1.10%	+1.3%	+12.3%	+12.7%	+21.9%	+11.9%	−8.9%	$882.8B
2	APPH	VanEck Pharmaceutical ETFRead Desk		0.36%	1.76%	+0.1%	+20.0%	+30.0%	+18.8%	+11.8%	−10.8%	$1.1B

End-of-day Nov 11, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus

5Y2 funds

#			Trend
1	BIVV	iShares Core S&P 500 ETFRead Desk		0.03%	1.10%	+1.3%	+12.3%	+12.7%	+21.9%	+11.9%	−8.9%	$882.8B
2	APPH	VanEck Pharmaceutical ETFRead Desk		0.36%	1.76%	+0.1%	+20.0%	+30.0%	+18.8%	+11.8%	−10.8%	$1.1B

End-of-day Nov 11, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus

Cards for this view

PPH

VanEck Pharmaceutical

$17,455

IVV

iShares Core S&P 500

$17,530

Loading…